UPDATE: Jefferies Upgrades Mirati Therapeutics (MRTX) to Buy
Tweet Send to a Friend
(Updated - May 10, 2021 7:47 AM EDT)
Jefferies analyst Maury Raycroft upgraded Mirati Therapeutics (NASDAQ: MRTX) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Maury Raycroft upgraded Mirati Therapeutics (NASDAQ: MRTX) from Hold ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
